LEO Pharma Inc. US Employee Directory
PharmaceuticalsNew Jersey, United States201-500 Employees
LEO Pharma Inc. operates as the U.S. affiliate of LEO Pharma A/S, headquartered in Madison, New Jersey, and has maintained a U.S. presence since 2009. The broader company was founded in 1908 and is owned by the LEO Foundation, with a sustained emphasis on developing treatments for skin conditions through research and development. Globally, LEO Pharma is headquartered in Denmark and employs around 5,000 people across 61 countries, underscoring its international footprint. In the United States, LEO Pharma Inc. markets dermatology-focused products and has activities around the availability of Adbry, which was announced for U.S. availability in 2024. The company’s portfolio includes international launches as well, such as Anzupgo cream for chronic hand eczema in Germany in 2024. A regulatory development noted in 2023 was an update to the U.S. prescribing information for enstilar Foam. The organization collectively positions itself within the pharmaceutical manufacturing industry with a dedicated focus on skin diseases and dermatologic therapies.
1-888-653-2347 
support@leadiq.com 
